<a href="https://laohu8.com/S/TWST">Twist Bioscience</a> Appoints Trynka Shineman Blake to Board of Directors, Enhancing Strategic Growth and Customer Experience Initiatives
Twist Bioscience Corporation has announced the appointment of Trynka Shineman Blake to its board of directors. She will also serve on the audit committee. Ms. Shineman Blake, who previously served as CEO of Vistaprint, brings extensive experience in corporate governance, customer experience, and digital transformation. Her appointment is expected to contribute to Twist Bioscience's strategic direction and growth as the company works towards achieving adjusted EBITDA breakeven and delivering innovative solutions.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Twist Bioscience Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20250806218674) on August 06, 2025, and is solely responsible for the information contained therein.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。